Despite the progress made in cancer treatment, difficulties are encountered with tumour targeting due to cancer structural complexity. The synthesis of homogenous calcium carbonate (CaCO 3 ) nanoparticles could be a carrier for doxorubicin in the management of bone cancer due to its osteoconductive and physicochemical properties with simple synthesis method to produce large scale. Among the nanocarriers, CaCO 3 nanoparticles have exhibited promising potential as targeting drug nanocarrier. The aim of this study is to synthesised and characterised doxorubicin-conjugated CaCO 3 nanoparticle (CS-CaCO 3 NP-DOX), using a simple precipitation and mechanical approach to synthesise homogeneous CaCO 3 NP from cockleshell. The oven-dried nanoparticles were further characterised for its physicochemical properties before and after conjugating with doxorubicin. A homogenous aragonite, spherical, porous nanocarrier was obtained with a mean diameter of 24.9 nm and zeta potential of −21 mV. The energy dispersion X-ray analysis revealed high proportion of calcium as a major element in the nanoparticle. The spectrum peak suggests little alteration upon incorporation of doxorubicin. Higher loading content and encapsulation efficiency were recorded with CS-CaCO 3 NP. These properties underscore the potential of CS-CaCO 3 NP in the delivery of doxorubicin, thus giving it a high potential for application in the delivery of the anticancer in the management of cancers.
INTRODUCTION
In the recently years, the great increase in the use of nanoparticles for biomedical applications has been observed in the area of molecular imaging, diagnosis, tissue engineering and targeted drug delivery. 9 14 37 This increased demand on nanocarrier has influence researchers in the field of nanomedicine to synthesise inorganic calcium carbonate nanoparticle from biogenic cockleshell for doxorubicin delivery. Although, series of the studies and methods have been developed towards synthesising and exploration of natural abundant material with at a low cost for pharmaceutical application in drug development. 1 11 24 34 66 Targeting drug delivery and nanotechnology currently has a great potential * Author to whom correspondence should be addressed. towards increasing and improving anticancer therapeutic index. 9 17 47 62 Although chemotherapy has been one of the standard treatments for cancers but the overwhelming drug resistance and lack of tumour specificity of the drugs offset the benefits of using the chemotherapeutic drugs. The development of nanoparticle with unique physicochemical properties from biological sources could become one of the modalities for chemotherapeutic drug delivery system to reduce systemic toxicity and improve therapeutic index, 60 using a simple synthesis method to produce large scale nanomaterial. There are several drug delivery system currently in use such as liposome, 15 noisome, 41 solid lipids. 16 Although the synthesis of such nanocarrier is quite challenging using simple processing method at very low cost with high production yield. 13 Nanocarrier with distinctive composition, shape, surface morphology and size are engineered to enable its application in drug delivery system. As one to the delivery system, homogeneous spherical aragonite cockleshell derived calcium carbonate nanoparticle (CS-CaCO 3 NP) has a great impact on the drug delivery due to the fact that it alters the efficacy of therapeutic agents by affecting the pharmacokinetics parameters. 52 The use of inorganic biobased material like aragonite calcium carbonate in delivery system has much advantage than the assembled organic polymers due to its biocompatibility properties, relative cost in synthesis process, surface structural porosity, stimuliresponsive with efficient loading capacity and high affinity for bone uptake, promote the therapeutic index of the drug it delivers in the system. 12 51 The structural surface porosity of the cockleshell derived aragonite polymorphic calcium carbonate nanomaterial encourages the incorporation of most water-soluble anticancer drug with good encapsulation efficiency to improve the drug bioavailability and distribution to targeted cells in the system. 51 Among the inorganic nanocarrier, biogenic CaCO 3 nanoparticles have exhibited promising potential as targeting drug carriers against cancer cells, due to the slow degradation of its matrices and biocompatibility. 53 However, calcium is essential for many biochemical activities starting from proliferation and development of cells, tissue contractile, haemopoietic regulation and apoptotic cells death, all associated to tumorigenesis process, nano-calcium carrier aids in improving the cellular requirement of cell viability of the normal mitotic cells through increase cytoplasmic calcium influx. 40 50 Table I. Summaries of previous findings on CS-CaCO 3 NP synthesised and their physicochemical properties.
References
Method of nano-synthesis physicochemical properties Remark/comments Wang et al. 60 61 Calcination process Cubic shape The product was challenged with agglomeration and instability as a result of the temperature used in the synthesis of the polymorphic crystals. Kamba et al. 51 Higher pressure homogenizer microemulsion system 50 nm (35-60 nm) Rod-shaped
The synthesis required expensive system, with less control on the end crystal size with poor dispersion quality. Hoque et al. 20 Rotor mill (Mechanical method)
Rod-like shape, micron-cubic shape and 20 m in length Physical grinding by roller mill alone produces low yield, of CaCO 3 NP with heterogeneity in the particle size associated with heavy metal contamination from milling pearl. Hariharan et al. 18 Precipitation method 28.64 nm, hexagonal shape The particle has broad polydispersity index, with different heterogeneous particle size making then not suitable for drug delivery. Zainal et al. 63 
Precipitation method
Rod-like to orthorhombic shaped
The nanoparticle produce was not-homogeneous in size with different particle shapes making the method alone not suitable for nano drug carrier development. Isa et al. 22 Higher pressure homogenizer microemulsion system 13.94-23.95 nm, spherical shape A heterogeneous size and diverse shapes were associated with microemulsion method, due to the inability to control size of the crystal particle produce. Saidykhan et al. 46 Precipitation method at higher temperature 80 C 34-36 nm, cubic shaped, −19.4 mV The fineness of the particle is mostly affected due particle surface charge causing agglomeration. However, high energy is required to generate high temperature. This method also is associated with imperfection of the surface morphology and crystallographic phase changes.
New nanocarrier systems are continuously being developed with the aim of improving the therapeutic index of conventional anticancer agents using inorganic homogenous porous biodegradable nanomaterial. Several attempts to use the nanoscale material in drug delivery system has assisted in the circumventing the systemic toxicity of a chemotherapeutic agent such as vincristine and doxorubicin used in the treatment of cancer. 32 Despite the research progress made in the synthesis of CS-CaCO 3 nanoparticle in the field of nanomedicine, available findings in the literature show inconsistent reports on the physicochemical properties of the particle as shown below in Table I. Many organic, synthetic and natural nanoscale products such liposome, gold, silver and dendrimers have been employed in the delivery of doxorubicin to neoplastic tissue. 35 Doxorubicin is a potent and widely use the antineoplastic drug for both haemopoietic and solid tumours but associated with dose-dependent cardiotoxicity, myelosuppression, which tend to reduce when the drug is loaded into nanoparticle. 28 41 As the delivery systems are mostly designed to either produce a controlled release or trigger release of it's conjugated agents at the site of action, the development of homogeneous aragonite CS-CaCO 3 NP with high loading content and entrapment efficiency is desirable for selective drug delivery specifically in the delivery of hydrophilic cytotoxic doxorubicin. The aim of this study is to synthesise homogenous aragonite cockle shell derived calcium carbonate nanoparticle conjugated with doxorubicin (CS-CaCO 3 NP-DOX). The development of homogeneous aragonite CS-CaCO 3 NP has great potential to improve therapeutic index of drugs and reduce associated toxicity with doxorubicin due to cell targeting ability through modification of the pharmacokinetics parameter. Secondly, it is inorganic, biogenic nanocarrier, with the ability to encapsulate hydrophilic and amphoteric drug molecules. Currently, CS-CaCO 3 Nanocarrier has thrown a lot of attention of researchers in the field of nanomedicine towards its usage in drug delivery due to its higher surface area, surface structural porosity with large loading content capacity, response to pH degradation, and abundant functional group ending such as carboxylic and hydroxyl group for electrostatic ion bonds. Its application in drug delivery system was earlier demonstrated on osteoblastic and human osteogenic cell lines for its cytotoxicity and biocompatibility. 53 The uniqueness of these is work is that it involves the combination of simple precipitation and mechanical method to yield a porous homogenous cockle shell derived calcium carbonate nanoparticle for doxorubicin delivery.
MATERIALS AND METHODS
Dodecyl dimethyl betaine (BS-12) was obtained from Sigma-Aldrich (Steinheim, Germany), the deionized water used as a diluent in the experiment is HPLC graded with a resistance of 18 M taken from Milli R06 plus Q-Water system (Organic). Doxorubicin hydrochloride (CAS Number 25316-40-9) was purchased from Tokyo chemical industry Company limited Japan with >95.0% purity, Acetonitrile, methanol, trifluoracetic acidic, acetic acid, sodium triacetate acid (Fisher Scientific, Malaysia). 3 Powder from Cockleshells In the preparation and synthesis of the CS-CaCO 3 nanoparticle, the method of Islam et al. 24 was adopted with few modifications. Briefly, cockle shells were washed with running tap water, boiled for 20 minutes in a steel container and washed in water containing bleaching agent (Bleach liquor, India) at the ratio of 3:1 (100 ml of water and 25 ml of the bleaching agent) with a brush to remove stains and remaining debris on the cockle shells and were oven dried again (Memmert UM 5000, Germany) at 50 C for 5 days. Rotary pulverising Blending machine (RT-08 rpm 2500, Taiwan) was used to grind the cockle shells into fine particles. The resultant fine powder of cockle shells was sieved with a laboratory steel sieve with pore aperture of 90 m and followed by another steel sieve with a smaller pore aperture size of 75 m (Endicott Ltd. London, England). The micron size CS-CaCO 3 powders were stored in a dry oven at 50 C.
Preparation of Micron Size CaCO

Synthesis of Nano-Sized CaCO 3 from
Cockleshell Power Precipitation method accomplished by mechanical milling was employed in the synthesis of the CS-CaCO 3 nanoparticle. Briefly, about 2 g of 75 m micron size CS-CaCO 3 powder were added to 50 ml of deionized water and then 0.5 ml of dodecyl dimethyl betaine (BS-12) was added to the aqueous solution in flat bottom flask within it's a magnetic stirring bar to enhance stirring and were placed on a Systematic Multi-Hotplate stirring machine (Systematic Multi-Hotplate Stirrers 6 Positions, WiseStir ® Korean) at 1000 rpm at 27 C for 2 hour, then the aqueous solution were filtered with filter paper (Pore size 18.0 cm, Filtre, Fioroni, China), and the surfactant (BS-12) were risen off through the filter paper using double deionized water and the resultant sediments are the nanoparticle which was allowed to dry in oven for 3 days at 50 C. The dried synthesis nanocarrier was further place in a glass cylindrical jar with a diameter size of 8 cm containing 7 ceramic balls and rolled on the ball miller at 200 rpm for 120 hours. The fine CS-CaCO 3 nanoparticle was then packaged in glass bottles and was stored in the oven at 50 C.
Characterization of CS-CaCO 3 Nanoparticles
Acceptable and good characterization of CS-CaCO 3 nanoparticles, for size, shape, surface charge, crystallinity and surface area is quite necessary for clinical application, although, could be quite difficult due to the nanocrystal polymorphic state and complexity of the synthesised nanocrystal.
Nanosize and Surface Morphology
The particle size and surface morphology of the CSCaCO 3 nanoparticles synthesis were determined using an advanced microscope; Transmission electron microscope TEM (Hitachi H-7100, Japan). Briefly, 0.1 mg of CS-CaCO 3 nanoparticle was dissolved in 3 ml of 100% acetone then sonicated for 30 min. A drop of the supernatant was added to a mesh carbon coated copper grid (Sigma-Aldrich, USA) with excess sample dried using filter paper and dropped on the Whatman paper (Fisher Scientific, Malaysia) in a petri dish, air dried and preserved in a desiccator for 48 hours before viewing while Field emission scanning microscopy (FESEM) was carried out using (JOEL 7600F, JEOL, Munchen, Germany) to determine the surface morphology as previously described by Saidykhan et al. 46 
Determination of Zeta Size, Potential and
Polydispersity Index (PDI) The mean nanoparticle diameter size, polydispersity index (PDI) and nanocarrier surface charge were determined using Zetasizer Nano ZS, Malvern instruments (Malvern Version 7.02, Malvern Instruments Ltd. UK) by dissolving 0.4 mg CS-CaCO 3 nanoparticle in 12 ml of deionized water which was sonicated for 30 mins and the supernatant loaded into the cuvette for the analysis according to the method employed by Isa et al. 22 with slight modification. All the measurements were made at a constant concentration in triplicates (n = 3) at a scattering angle
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Crystalline Stability Determination at Different
Storage Temperature The crystalline stability of the synthesised CS-CaCO 3 NP stored in an aqueous solvent (PBS 7.4) at a constant pH of 7.9 at different storage temperature of 4 C, 25 C and 50 C were determined using Zetasizer Nano ZS, Malvern instruments at three predetermined periods within the range of 0 to 5 months. All the procedure were in accordance to Isa et al. 22 method with slight modification.
Elemental Analysis
The elemental composition of the CS-CaCO 3 nanoparticle was determined with Energy dispersion X-ray (EDX) to quantify the elementary composition of the cockle derived calcium carbonate nanoparticle using field emission scanning electron microscope (JOEL, 7600F) attached with energy dispersive X-ray spectroscopy.
FT-IR Chemical Analysis
Functional group endings of the CS-CaCO 3 Np, CSCaCO 3 Np-Dox and Dox were determined using Fourier infrared spectrophotometer (FT-IR) (Model 100 series, Perkin Elmer) at a range of 4000 cm −1 to 280 cm −1 with a resolution of 2 cm −1 and an average scan of 64 times according to Kamba et al. 52 method.
X-ray Powder Diffraction (XRD) Determination
The crystalline nature and purity of the CS-CaCO 3 nanoparticle, CS-CaCO 3 NP-Dox and Doxorubicin were determined using a Shimadzu XRD-6000 powder diffractometer (Shimadzu Corporation, Japan) at CuK ( = 1 540562 A) 30.0 kV and 30 mA on a continuous scanning process within the range of 5.0 to 60.0 diffraction angle, at a speed of 2.000 (deg/min) at 37 C as earlier described by Saidykhan et al. 46 Briefly, 500 mg of each of the sample were used to fill up the holder using standard fill back approach.
Specific Surface Area and Pore Size
Determination The BET specific surface area of the synthesised CSCaCO 3 NP was determined using 3 flex surface characterization analyser (Micromeritrics, Instrument Corporation, USA) with Nitrogen gas adsorption/desorption isotherms method at 77.25 K using a total sample weight of 0.1889 g with the sample initial outgassed at 90 C for 60 min. Base on the adsorption and desorption isotherm at a relative pressure range of (P /P 0 ) from 0.01 to 0.991, the data generated were used to determine the BET specific surface area, isotherm type.
Pharmaceutical Characterization
Drug Loading Capacity and Encapsulation
Efficiency of CS-CaCO 3 Nanoparticle Assay The concentration of drug entrapped by the CS-CaCO 3 nanocarrier is essential in the drug delivery system. Thus it is fundamental to determine the amount of drug entrapped per the ratio of the carrier used. 44 A standard calibration curve for absorbance measurement of doxorubicin concentration range of 500-3.9 ug/ml in deionized water as a solvent was generated at a wavelength of 485 nm. The amount of unencapsulated drug concentration was deduced from the concentration of the drug in the supernatant to obtained the weight of encapsulated doxorubicin concentration.
Six experimental groups of nanocarrier drug loading were analysed with 25 mg of the CS-CaCO 3 nanoparticles being loaded with 8 mg doxorubicin, 6 mg doxorubicin and 4 mg doxorubicin all dissolved in 10 ml of deionized water and stirred in the dark room at 200 rpm overnight with the other three groups, conjugated with 10 mg of CS-CaCO 3 nanocarrier and doxorubicin. The separation of entrapped doxorubicin from nanoparticle was achieved by ultracentrifugation at 20,000× g for 20 min at 27 C (Optima XPN, Beckman Coulter instruments Inc., CA, USA) and washed with deionized water twice and freeze-dried. The drug loading content and encapsulation efficiency of the CaCO 3 nanoparticle were analysed by calculating the difference between the total amount of the drug feed and the un-trapped drug concentration in the supernatant liquid of the suspension per weight of CaCO 3 nanoparticle. The amounts of the free drug in the supernatant aliquot were determined by measuring the absorbance at 485 nm with High-pressure liquid chromatography (HLPC, Water 2960 UV detector). Data in triplicate measurement with independent values drug loading capacity (DLC %) and encapsulation efficiency (EE %) of nanoparticle were calculated as stated in the Eqs. (1) and (2) Where NP = Nanoparticle as previously determined by Rahman et al. 44 
Analytical Method Development and
Chromatographic Status A reverse phase HPLC analytical method modified to detect doxorubicin free from the loading process for the determination loading content and encapsulation efficiency was used. 7 The system (Water 2690) with a single pump and a column of Agilent Eclipse C18, 4.6 mm × 250 mm, 5 m and UV-detector Photodiode Array UV/Vis 2D detector, (W2998, Waters Corp., USA) connected to Empower 2 software were using. The detector was set at 290 nm with a mobile phase of methanol and water (40:60, pH 4.8). The methanol mobile phase was flowing at 40% at 0 min, 95% at 5 min, 95% at 8 min, 40% at 9 min, and 40% at 13 min. A flow rate 1 mL/min and 30 uL injection volume at 30 C. The retention time of doxorubicin was at 4.8 minutes with a total run time of 18 minutes.
Statistical Analysis
All the data generated were presented in tables and chart, which are expressed as mean, standard deviation and percentages with the date obtained from triplicate repeated experiment and analysed using SPSS version 22 and Origin version 6.
RESULTS
The broad objective of this article is to developed homogenous monodispersed aragonite calcium carbonate polymorph nanoparticle derived from cockle shell for doxorubicin delivery. All the data presented in the study are mean of the triplicate experiments. Nanoparticle size, Zeta potential, polydispersity index, drug loading content, and encapsulation efficiency. The results were mostly expressed as average value ± SD.
Characterization of CS-CaCO 3 NP and CS-CaCO 3 NP-Dox
Nano-Size Determination Using Transmission
Electron Microscopy (TEM), Surface Morphology (FESEM) Transmission electron microscopy reveals an average nanoparticle size of 24 9 ± 3 1 nm, with a range between 11.0-46 nm in diameter (Table II) with uniform spherical shaped nanoparticle and porous surface area though few amount of the nanoparticle aggregate on the TEM photomicrograph view (Figs. 1-3 ). The Gaussian distribution demonstrated an average particle of 24.9 nm (Fig. 3) . The field emission electron photomicrograph reveals homogenous unidimensional spherical shaped surface morphology as shown in Figure 4 . Polydispersity index is an important parameter for CSCaCO 3 nanocarrier which explains the uni-dispersity of the particle in a colloidal solvent and stability. The CSCaCO 3 nanocarrier and CS-CaCO 3 NP-Dox produced in this study were 142 0 ± 2 1 nm, 0.120 and 185 6 ± 2 4, 0.304 respectively. The high surface charge potential might have contributed to its stability in colloidal form (Figs. 5(a,b) ).
Stability of CS-CaCO 3 NP at Different
Storage Temperature There was a relative increase in particle diameter size and polydispersity index (PDI) in physiological aqueous solvent simulated at both room temperature 25 C and freezing temperature of 4 C, with relative stable size and crystalline dispersion of the CS-CaCO 3 NP when stored in oven at 50 C up to a period of 5 months as shown in Table III below.
Elementary Analysis of CS-CaCO 3 NP
The Elementary analysis showed the presence of calcium, carbon and oxygen as the major element present on the CS-CaCO 3 nanoparticle with a greater proportion of the compound contain carbon and oxygen compared to the ratio of calcium as shown in Figures 7, 8 . 
FT-IR Chemical Analysis
The functional group of the CS- 3 ) on the CS-CaCO 3 NP and CS-CaCO 3 NP-DOX as shown in Figure 9 . 
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X-ray Powder Diffraction (XRD) Analysis for Crystallinity
The absorption peaks demonstrated by the CS-CaCO 3 NP and CS-CaCO 3 NP-Dox were similar with both having absorption peak emerging at 2 theta of 22.3 and 33.0 indicating that the crystalline phase of CS-CaCO 3 NP is maintained after loading the nanocarrier with doxorubicin which has some of its absorption peak appearing earlier at within diffraction angle of 10-20 ( Fig. 10) .
Specific Surface Area and Pore Size
Determination The BET isotherm pattern observed reveal that the synthesis CS-CaCO 3 Np is a type III mesoporous with hysteresis isotherm material elucidating the multilayer nature of the synthesised nanoparticle with a sharp slope at a relative pressure of between 0.1-0.9 with an average BET specific surface area and BJH mean pore size diameter of 6 1818 ± 0 65 m 2 /g and 4.48 nm respectively as shown in Table IV and Figure 11 3 Nanoparticle Assay A higher loading content and encapsulation efficiency were demonstrated by CS-CaCO 3 NP, when loaded with doxorubicin with variation in the loading capacity and encapsulation efficiency as a result of a change in the ratio of CS-CaCO 3 NP to DOX composition in the formulation. A significant increase in loading content and encapsulation were shown when the molecular weight of the CSCaCO 3 NP reduces to 10 mg as at when compared to 25 mg of CS-CaCO 3 NP as shown in Figure 12. 
Pharmaceutical Characterisation
Drug Loading and Encapsulation Efficiency of CS-CaCO
Higher Pressure Liquid Chromatograph (HPLC)
Analytical Method for Drug Loading Content and Encapsulation Efficiency The HPLC reverse phase analytical quantification method for free doxorubicin has a retention time of 4.80 min with a linearity (R 2 = 0 9978) were determined for computing loading content capacity and drug encapsulating efficiency as shown in Figure 13 . 
DISCUSSION
This study was carried out to synthesise homogeneous CSCaCO 3 nanoparticle for its potential use in the delivery of doxorubicin in dogs bearing bone tumour. Calcium carbonates are widely available in a different polymorphic form with aragonite polymorph abundant in seawater source. 59 The physicochemical characteristics of the nanocarrier play a major role in the drug loading, control release, prolong plasma circulation, tissue penetration which finally lead to improve therapeutic efficacy. It is widely accepted that physicochemical properties of nanocarrier affect the biological system which influences its biodistribution and safety in the biological system. 38 The CS-CaCO 3 particle size observed by both Transmission electron microscopy (TEM) and dynamic light scattering (DLS) was found to be adequate enough for nano delivery since nanoparticulate sizes were below 200 nm in diameter which is also acceptable for intervenous administration. 30 The more disperse distribution demonstrated by the synthesised CSCaCO 3 NP were as a result of the modification in the synthesis method when compared the nanocrystals particle produced by Kamba et al., 52 Saidykhan et al. 46 TEM demonstrate virtual dispersion of CS-CaCO 3 nanoparticle which enables individual measure of the average particle size. The different techniques employed in the synthesis process in the fabrication of nanoparticle for drug delivery has enabled variation in drug carrier geometric. The variation in physicochemical properties of CS-CaCO 3 nanoparticle concurs with findings published by Hariharan et al., 18 who observed that CaCO 3 nanoparticle exhibited different physicochemical characteristics with variation in the methods employed during the synthesis process.
Our finding with respect to the particle size was similar to reports by Isa et al. 22 and consistency with Zubair et al., 65 though nanocrystals reported by these researchers were associated with some degree of agglomeration when compared to what were observed in the present study. Carbonation process in the presence of surfactant used might have aided in breaking down the particle size to smaller ones and thus achieving a better dispersion as observed in the present findings. The difference observed in the two techniques used in the determination of the particle diameter size was that TEM was real time measurement of single particle based on exposure in a high vacuum electron beam column while Nanosizer (Photon correlation spectroscopy) uses Brownian displacement principle. 51 The average size with spherical shape of nanocarrier concurs with the findings of Islam et al., 24 thus the particle size synthesised in this work were smaller in diameter size. However, it is somewhat similar to the range (12-30 nm) reported by Kamba et al., 52 when cockle shell powder was microemulsified using a higher pressured homogeniser. Monodispersion and uniformity in respect observed with the synthesised particle size were due to the fact that percentage of the surfactant added was reduced and wash out thoroughly when compared concentration and the method used by Islam et al. 24 Moreover, the dry nanocrystals were placed on a ball mill thus making the mixture more homogenous and perhaps reducing the chances of agglomeration. A slight constant increase in the particle size was observed with Nano zeta size, which agrees with the finding of Jiang et al., 26 that there is a tendency for a slight increase in particle size with nano zeta sizer when compared to the real time TEM. It has been reported that nanotherapeutic with small diameter size escapes entrapment by macrophages which aid in accumulation in the liver and spleen and causes nonspecific distribution the released drug to healthy cell and tissue, thus making the size synthesis promising in Nanotherapeutics for the management of bone tumours. 4 A porous surface was observed on the synthesised CSCaCO 3 nanoparticle, which likely gives the particle an additional advantage to effectively load and delivers the candidate therapeutic drug. This finding is similar to the reports of Lee et al. 31 and Bharatham et al., 3 who documented roughness of calcium carbonate surface due to its porous nature. The porous surface nature seen on CSCaCO 3 nanoparticle was similar to the aragonite crystals reported by Walsh and Lebeau, 6 but more disperse with less aggregation, which could be attributed to vigorous surfactant clearing by washing with deionized water and mechanical grinding by the ceramic glass on ball milling machine. The synthesised CS-CaCO 3 nanocarrier with a porous surface, small diameter size with large surface area for interaction make it a good potential drug carrier which concurs with report of Sharma et al., 55 that controlled size, surface area and porosity, influences nanotoxicity in biological system.
Initial synthesis had resulted in agglomeration and clumping of the particle, thus it was assumed that the striking forces by the ceramic balls in the ball milling machine might have aided in achieving a better dispersion of the nanoparticle as later observed in the present study. In this study, a spherically shaped nanoparticle was observed following TEM, this was contrary to the report of Shimpi, et al., 56 who reported a cubic shaped CaCO 3 nanomaterial after subjecting the synthesised particle to TEM. Studies have suggested that the cubic shape calcium carbonate is mostly associated with calcite polymorph form synthesised from the chemical precipitation with limestone as the material source. Also, contrary to our findings, Kamba et al., 52 reported a rod-shaped CS-CaCO 3 nanoparticle which was synthesised using higher pressure homogenizer system, thus suggesting that variations in the shape of the synthesised nanoparticle may be associated with the synthesis procedure employed. Importantly, particle shape has been reported to play a vital role in the biodistribution and cellular internalisation of the loaded therapeutic agent. 42 In this regards, spherically shaped inorganic nanoparticle possesses large surface area for interaction with biological matrix making them more superior in drug delivery. 24 
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Development of Cockleshell (Anadara granosa) Derived CaCO 3 Nanoparticle for Doxorubicin Delivery Carbonation technique used in the synthesis process which involves the addition of BS-12 as a surfactant helps in maintaining the particle shape probably due to constant temperature and carbon dioxide gas emission during the synthesis process. 27 Although, Saidykhan et al., 46 reported a rod-shaped CS-CaCO 3 nanoparticle used for vancomycin delivery which is contrary to our finding, in which this variation was attributed to the higher temperature of 80 C used. However, agrees with the earlier findings of Kadota et al. 27 with regards to control nanoparticle morphology. When temperature above ambient temperature is employed in the synthesis a rhombic shape calcite was reported which possess less quality for drug delivery. Increase temperature in calcium carbonate nanoparticle synthesis by decomposition through carbonation process decrease carbon dioxide solubility in water. The spherical shape of the CS-CaCO 3 nanoparticle synthesised was contrary to the finding of Hoque et al. 21 who record rod to needle-like shaped feature when micron crystal of cockle shell powder was evaluated using scanning electron microscopy. It is expected that spherical nanoscale carrier particle flows freely in the blood vessel avoiding the biological barriers which conform with the statement of Blanco et al., 4 who reported that spherical particles move freely as compared to the shape of blood cells in the blood vessel which aided in the biodistribution of the chemotherapeutic.
The porous nature of the CS-CaCO 3 nanoparticle synthesis has a great advantage on drug incorporation and encapsulation efficiency. The porous surface observed were similar to what was reported by Walsh and Lebeau, 6 Shimpi et al., 56 that micron crystal calcium carbonate has rough and hollow space on the surface which aid in interaction with the biological system.
The low polydispersity index expressed by CS-CaCO 3 nanoparticle synthesised in this work indicates narrow distribution of size with mono-dispersion of the carrier molecules, which allow an even distribution of loaded drug. The mono-modal characteristic expressed by the CSCaCO 3 nanoparticle will probably serve as a good feature for intravenous administration. Generally, surface potential of a nanocarrier predicts the colloidal stability of the particle in suspension. Aggregation is less likely to occur on nanoparticle with higher surface charge of greater than 30 mV irrespective of its positive or negative values. 29 In this study surface potential obtained with CS-CaCO 3 Np was similar to the reports of Saidykhan et al. 46 with −15 mV for aragonite calcium carbonate nanoparticle used for the delivery of vancomycin. In a different study, Isa et al. 22 reported a somewhat similarly negative potential charge even though the method used in the synthesis was quite different from ours. The result in this work is as well contrary to the report of Lee et al., 31 who reported a positive value of surface potential for aragonite polymorph, moreover, the pH value of the solvent medium could attribute to the surface charge differences observed.
The negativity of the surface increases upon incorporation of the nanocarrier with doxorubicin due to an electrostatic ionic charge of doxorubicin polycationic surface, which was also demonstrated by Saidykhan et al., 46 when aragonite calcium carbonate polymorph was used to deliver vancomycin and agrees with the findings of Zhou et al. 64 in polyelectrolyte graphene oxides with negative charge potential due to the functional group endings. Functionally, the negative surface potential of both CS-CaCO 3 NP and CS-CaCO 3 NP-Dox could help in repulsion mechanism within the blood stream and prevent phagocytosis which invariably improving doxorubicin biodistribution. 19 The increase in the potential of the loaded CS-CaCO 3 nanoparticle with doxorubicin indicates strong electrostatic force which is responsible for high repulsive force within the CS-CaCO 3 nanoparticle that averts agglomeration in a solvent. The higher negative potential demonstrated by CS-CaCO 3 nanoparticle suggested higher stability of the carrier particle in the colloidal formulation. Since colloidal stability of nanoparticle is measured by it zeta potential demonstrated with zeta potential value 30 mV either positive or negative considered stable. 29 The higher electrostatic charge on the surface particle thus inhibits agglomeration and mostly associated with low polydispersity index as demonstrated by CS-CaCO 3 nanoparticle. The surface potential of the carrier molecule plays an important role in the biodistribution, bioavailability and pharmacokinetics of drug by aiding in protein binding and interaction. 4 However, the neural to negative charge liposomes nanocarrier were report by Sharma and his coworks in 2012 to have no toxic effect on haematopoietic cells when used as drug carrier in the delivery system.
The aragonite polymorphs of the synthesis were maintained in an aqueous solvent of pH 7.9 for 5 months at storage temperature of 50 C. As earlier, reported by Santomauro, 48 synthesis of aragonite polymorphs are favoured at higher temperature in aqueous solvent. The relative increase in particle diameter size with temperature could be explained using Gibbs-Thomson effect. Moreover, the electrostatic force interacting between calcium ion carbonate anion in presence of hydrogen linkage due to the thermodynamic charges of polymorphic state of CS-CaCO 3 NP synthesis and change observed. 5 8 The transition of aragonite nanocrystal to calcite mostly occurs rapidly in low temperature as earlier seen in the aragonite polymorph synthesised from coral and marine shells. 52 However, Kamba et al. 52 reported that calcium carbonate nanocrystal remains unchanged at temperature below 800 C in which above these it decompose to carbonate ion. The increase stability observed at higher temperature could be attributed to the negative charge electrostatic potential of the nanocarrier synthesised which consistent to the earlier report of Pinto et al., 43 when liposomal nanostructured with negative charge surface were employed to delivery doxorubicin in mice.
The elemental composition of the CS-CaCO 3 nanoparticle synthesised were evaluated using energy dispersive X-ray system, in which the spectrum peak showed that carbon and oxygen have higher elemental atomic percentage ratio compare to calcium. These findings are similar to the reports of Hoque et al. 21 and Islam et al., 24 when both nanoscale crystal and micron structured powder from cockle shell were evaluated. The elementary energy dispersive X-ray clearly confirms the presence of high calcium atomic ratio in the synthesised CS-CaCO 3 nanoparticle. Rusnah et al. 36 reported 11.38% of calcium atomic percentage lower compared to carbon and oxygen atomic percentage of 53.47% and 28.0% respectively in their work of hydroxyapatite from cockle shell for bone grafting which was slightly higher to what was demonstrated by CS-CaCO 3 nanoparticle. Contrary to the findings by Mohamed et al. 39 and Rashidi et al., 45 the proportion of calcium atom percentage were higher than carbon and oxygen in calcium carbonate synthesised from cockle shell, though the variation was attributed to calcination process involving high temperature during the decomposition to produce calcium oxide. Majorly, calcium, carbon and oxygen indicating the purity of CS-CaCO 3 nanoparticle with little traces of Aluminium, copper and sodium which were attributed to the stub coated material used in the analysis as the source of this trace materials although this finding were contrary to report of Kamba et al. 52 who reported that aragonite polymorph synthesis from cockle shell is not 100 percent pure to the presence of another trace element.
The presence spectra peak of 1448, 1077, 851 and 707 were quite similar to the spectra peak of 1455, 1083, 857, and 706 cm −1 representing aragonite nanoparticle with slight shift in both CS-CaCO 3 aragonite nanoparticle and CS-CaCO 3 NP-Dox formulation. 23 25 34 However, the absorption spectrum peak of 1083 and 851 cm −1 were reported peaks for CO 2− 3 as earlier suggested by Kamba et al. 52 The result of doxorubicin and CS-CaCO 3 nanoparticle incorporation clearly indicate that the functional peak of the doxorubicin remains unchanged with clear spectra peak for amide functional group on the loaded CSCaCO 3 nanoparticle. Islam et al., 24 report both micron and nanoparticle of calcium carbonate has a unique spectrum peak of 1455 cm −1 in common, which was as well expressed by CS-CaCO 3 nanocarrier spectra. The spectra peak signature also had similar pattern as compared to the peaks 1464, 874 and 713 cm −1 of CaCO 3 nanoparticle demonstrated by Lu et al. 57 Hariharan et al. 18 used a spectra peak of 876.72 cm −1 to confirm the presence of aragonite calcium carbonate nanoparticle synthesised from cockle shell with similar peak signature observed but with slight shift. The present of the spectra at the peak of 3310, 1723 and 986 indicate the incorporation of doxorubicin on the aragonite nanocarrier since spectrum peaks of 2507, 1724 representing stretching vibration of N-H from (CH)-NH 2 + and NH 3+ stretch of the doxorubicin with spectra peak of 3310 shows O-H stretch. 60 61 reported the presence signature peak BS-12 signature as 2993 and 2875 in the carbonation method used in the synthesis of calcite polymorph of calcium carbonate which was using in the modifying the shape of the carrier particle. The absence of diagnostic IR spectra peak of 712 cm −1 that represent the signature of calcite and 747 cm −1 , 1085 cm −1 representing vaterite as reported by Saraya et al. 49 lead to the conclusion that the spectrum signature observed in this studies represent aragonite polymorph calcium carbonate nanocrystal. The simple precipitation method employed aided in the expression of crystalline due to carbonation process resulting to supersaturation and balancing ionic Ca 2+ and CO 2− 3 ratio which agrees with the finding of El-Sheikh et al. 10 in their work explaining the effect of cationic surfactant on the inorganic nanoparticle synthesis. This result shows that loading of doxorubicin on CS-CaCO 3 nanoparticle does not cause such alterations in the crystalline nature of the carrier in respect vibration frequencies observed with the additional peak indicating the presence of NH 3+ amide functional group of doxorubicin. The resultant change in the spectra demonstrate by the CS-CaCO 3 NP indicate Dox was fully entrapped in the CS-CaCO 3 NP core.
The crystalline phase of materials is excellently evaluated and monitored using XRD analytical system. 22 The high absorption peak pattern demonstrated by CSCaCO 3 NP and CS-CaCO 3 NP-Dox were consistent with the report of Kamba et al. 51 who documented the presence of the absorption peak at 2 values of 26.34 , 33.24 , 45.98 which were all corresponding the absorption peak demonstrated by CS-CaCO 3 NP and CS-CaCO 3 NP-Dox. The diffraction peak observed on the CS-CaCO 3 NP were confirmed when compared with the reference diffraction peak of aragonite calcium carbonate nanocrystal (JCPDS file no 00-041-1475). 24 The high intensity of the absorption peak strongly indicates that crystalline array fashion remains unchanged even after loading with doxorubicin.
The specific surface area demonstrated by CSCaCO 3 NP was quite good enough for the particle size synthesised from cockle shell, however, the result of the surface area of CS-CaCO 3 NP has not been reported in all the previous reports to the best of our knowledge, which were also consistent with the findings of Bang et al., 2 that the specific surface area of the precipitated calcium carbonate particle was within the range of 3 83 ± 0 02 nm to 29 62 ± 0 02 nm for small to large particle size. Although, Lee et al., 31 reported an average specific area for calcite polymorphs of calcium carbonate as 15.8 m 2 /g used for oral drug carrier. The Brunauer, Emmett, and Teller theory were mostly applied for specific surface using Nitrogen as a standard adsorbent for determining pore size and surface area. 58 The pores are displayed usually in an irregular shape from the exterior with a pore dimension in diameter of 1-200 nm. 32 58 According to pore size classification, CS-CaCO 3 NP with a diameter size with 2-50 nm is referred to as mesoporous less than 50 nm which is referred to the macroporous material.
The size range of the CS-CaCO 3 nanoparticle obtained attributed to the increase in the loading content capacity and Encapsulation efficiency as when compared to the reports of Kamba et al. 52 which also concur with the findings of McNeil, 38 who observed that decrease particle size with increases the surface area of the carrier molecules which invariability increase the encapsulation efficiency. The determination of drug delivery potential of a carrier lies on the loading content ability and its release fashion. The porous nature of the nanocarrier and solubility of the drug help further in the higher encapsulation efficiency observed. Drug loading capacity and release are inter-related because of the surface chemistry interaction between the CS-CaCO 3 nanoparticle matrix, surface charge and functional group ending of doxorubicin hydrochloride. 52 The high percentage drug encapsulation efficiency further confirms that the required therapeutic dose needed to reach the targeted tumour site will be achieved.
The high loading capacity of CS-CaCO 3 nanoparticle is sufficient enough to deliver doxorubicin to neoplastic tissue in the biological system. Nanocarrier tends to efficiently protect the bioactive drug from degradation by a biological system, change in environmental factors and provides targeted control release by way prevent unwanted interaction with cells. The higher loading content of 75% observed by the CS-CaCO 3 NP could be attributed the homogeneity and the less nanocarrier weight used in this study, as the composition ratio of the nanocarrier and drug, thus shows to affect the loading content capacity as when compared to the works of Kamba et al. 52 Thus, CS-CaCO 3 nanoparticle has the potential to entrap more doxorubicin than other inorganic and organic nanocarrier used in the delivery of doxorubicin. An increase in the drug encapsulation efficiency with corresponding increase in CS-CaCO 3 nanoparticle weight used in the loading process agree with reports of Shahbazi and Hamidi, 54 who observed clear increase in the encapsulation efficiency percentage of heparin on chitosan as the molecular weight of Nanocarrier increases, reason been that as the molecular weight of chitosan increase the polymer chain and functional group ending for interaction with heparin molecules increases. Although in this study, increase in loading content capacity were demonstrated with increase molecular weight of CSCaCO 3 nanoparticle which are attributed to doxorubicin solubility, small particle diameter size, carboxyl functional group ending as demonstrated by the spectra peak of the nanocarrier and porous particle matrix which could all contribute to the ionic interaction resulting high loading content capacity. The higher loading capacity and encapsulation efficiency demonstrated by CS-CaCO 3 nanoparticle with low nanocarrier weight indicate that CS-CaCO 3 nanocarrier is potential material for drug delivery system with less quantity of the carrier matrix used.
CONCLUSION
In the present study, the synthesised CS-CaCO 3 nanoparticle was shown to have a good polydispersity index suggesting homogenous size and good distribution in aqueous solvent. In addition, doxorubicin was successfully loaded on the CS-CaCO 3 NP thus giving it a high potential for application in the delivery of the anticancer drug in the therapeutic management of bone cancers. The physicochemical properties demonstrated by CS-CaCO 3 nanoparticle could as a preliminary assay assessment towards evaluating its nanotoxicity effect in biological system. These results herein show that CS-CaCO 3 NP synthesis has higher loading capacity for Doxorubicin delivery on dogs bearing bone tumours.
